Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS 2023-03-25 02:51
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib 2023-02-21 14:00
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe 2023-02-16 14:00
Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition 2022-12-15 14:00
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib 2022-10-28 13:00
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency 2022-08-02 13:00
Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS 2022-08-01 13:00
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
1